Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Recce Pharmaceuticals Ltd. ( (AU:RCE) ) has issued an update.
Recce Pharmaceuticals Ltd has announced the quotation of 12,273,033 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of May 16, 2025. This move is part of previously announced transactions and is expected to enhance the company’s financial position, potentially impacting its market presence and stakeholder interests positively.
More about Recce Pharmaceuticals Ltd.
Recce Pharmaceuticals Ltd is a company operating in the pharmaceutical industry, focusing on the development and commercialization of novel synthetic anti-infectives designed to address the growing problem of antibiotic-resistant superbugs and emerging viral pathogens.
Average Trading Volume: 218,078
Technical Sentiment Signal: Sell
Current Market Cap: A$79.8M
Find detailed analytics on RCE stock on TipRanks’ Stock Analysis page.